HomeCarboplatinCarboplatin + Bevacizumab Adcd

Does Carboplatin Interact with Bevacizumab Adcd?

Carboplatin and Bevacizumab Adcd have a minor drug interaction according to U.S. FDA drug labeling data. No clinically meaningful effect on pharmacokinetics of carboplatin when administered with bevacizumab. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Minor
Carboplatin Class
Platinum-based Drug
Bevacizumab Adcd Class
Vascular Endothelial Growth Factor Inhibitor
Management
Generally manageable
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Carboplatin and your doctor is considering prescribing Bevacizumab Adcd (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Carboplatin(Paraplatin)+💊 Bevacizumab Adcd(Vegzelma)

Severity & Interaction Details

minor
Generally safe — minor interaction
Low clinical significance. Routine awareness is usually sufficient.
Severity scale
MinorContra
On record
Yes
Drug A class
Platinum-based Drug
Drug B class
Vascular Endothelial Growth Factor Inhibitor
Source
NLP:bevacizumab-adcd

What this means in plain English

No clinically meaningful effect on pharmacokinetics of carboplatin when administered with bevacizumab.

About Carboplatin and Bevacizumab Adcd

Carboplatin is a Platinum-based Drug, while Bevacizumab Adcd is a Vascular Endothelial Growth Factor Inhibitor. You may recognize them by the brand names Paraplatin and Vegzelma. Both medications are given by intravenous (IV) infusion. Carboplatin additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Carboplatin and Bevacizumab Adcd against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.